TrialDiabetes, obesity & metabolism2025

Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, phase 3 trial.

Leili Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.